<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/CDCAE774-FDAC-4F8A-A355-F2B4F9A27686"><gtr:id>CDCAE774-FDAC-4F8A-A355-F2B4F9A27686</gtr:id><gtr:name>Alcyomics Ltd</gtr:name><gtr:department>Research</gtr:department><gtr:address><gtr:line1>Hematalogical Sciences</gtr:line1><gtr:line2>Inst Cellular Medicine</gtr:line2><gtr:line3>Framlington Place</gtr:line3><gtr:postCode>NE2 4HH</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CDCAE774-FDAC-4F8A-A355-F2B4F9A27686"><gtr:id>CDCAE774-FDAC-4F8A-A355-F2B4F9A27686</gtr:id><gtr:name>Alcyomics Ltd</gtr:name><gtr:address><gtr:line1>Hematalogical Sciences</gtr:line1><gtr:line2>Inst Cellular Medicine</gtr:line2><gtr:line3>Framlington Place</gtr:line3><gtr:postCode>NE2 4HH</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A76D16B7-6835-4476-9B66-C5DC92E67A0F"><gtr:id>A76D16B7-6835-4476-9B66-C5DC92E67A0F</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Genever</gtr:surname><gtr:orcidId>0000-0002-5730-8976</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/14D4F6E9-38DF-48E6-AF95-7AA08DA053F8"><gtr:id>14D4F6E9-38DF-48E6-AF95-7AA08DA053F8</gtr:id><gtr:firstName>Kenneth</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Dalgarno</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D85AE08B-41E4-448F-852C-710E22FF34E7"><gtr:id>D85AE08B-41E4-448F-852C-710E22FF34E7</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>G</gtr:otherNames><gtr:surname>Pearson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8A99DCBD-0C0A-4AFB-89EE-04D2E15981FA"><gtr:id>8A99DCBD-0C0A-4AFB-89EE-04D2E15981FA</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:otherNames>Mary</gtr:otherNames><gtr:surname>Dickinson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A9264347-0224-4AE9-99BB-0684330D0A76"><gtr:id>A9264347-0224-4AE9-99BB-0684330D0A76</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Loughlin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=NS%2FA000070%2F1"><gtr:id>C181D996-B473-4ED4-A84C-AC4CC97FE7C5</gtr:id><gtr:title>Microfluidic Automated Platform for Osteoarthritis Drug Screening (MA-PODS)</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Other Grant</gtr:grantCategory><gtr:grantReference>NS/A000070/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2020-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2017-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>333332</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">NS/A000070/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>195B48B4-2BC5-4DEB-BA1A-323A90D8730D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Tissue engineering</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>